FCM
Farallon Capital Management Portfolio holdings
AUM
$15.3B
1-Year Est. Return
51.42%
This Fund
S&P 500
1 Year Est. Return
+51.42%
AUM
$15.3B
AUM Growth
-$2.87B
(-16%)
Holding
201
Top Buys
| 1 | +$292M | |
| 2 | +$280M | |
| 3 | +$248M | |
| 4 |
Mastercard
MA
|
+$138M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$133M |
Top Sells
| 1 | +$650M | |
| 2 | +$470M | |
| 3 | +$334M | |
| 4 |
Nasdaq
NDAQ
|
+$290M |
| 5 |
RNAM
Avidity Biosciences
RNAM
|
+$233M |
Sector Composition
| 1 | Healthcare | 57.82% |
| 2 | Financials | 13.96% |
| 3 | Technology | 12.78% |
| 4 | Consumer Discretionary | 5.83% |
| 5 | Industrials | 4.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Mastercard
MA
$417B
| $217M | 1.42% |
435,071
+262,400
|
|
||
27
McKesson
MCK
$88.6B
| $203M | 1.32% |
234,300
-64,600
|
|
||
28
Agios Pharmaceuticals
AGIO
$1.58B
| $192M | 1.25% |
5,684,000
+524,495
|
|
||
|
CNTA
29
Centessa Pharmaceuticals
CNTA
$6.17B
| $191M | 1.25% |
4,809,000
-568,068
|
|
||
30
Tango Therapeutics
TNGX
$3.11B
| $190M | 1.24% |
9,097,411
-3,964,000
|
|
||
|
GRAL
31
GRAIL Inc
GRAL
$2.62B
| $168M | 1.1% |
3,253,684
+911,000
|
|
||
32
Tyra Biosciences
TYRA
$1.7B
| $137M | 0.89% |
3,580,818
+1,514,000
|
|
||
33
Tenet Healthcare
THC
$14.1B
| $85.3M | 0.56% |
452,153
+80,000
|
|
||
34
Cardinal Health
CAH
$45.6B
| $77.8M | 0.51% |
368,000
-208,000
|
|
||
35
Vaxcyte
PCVX
$6.85B
| $73.3M | 0.48% |
1,261,000
+1,256,000
|
|
||
36
Dianthus Therapeutics
DNTH
$4.64B
| $70.2M | 0.46% |
+836,000
|
|
||
37
BrightSpring Health Services
BTSG
$11.8B
| $68.9M | 0.45% |
1,617,000
+1,595,000
|
|
||
38
Twist Bioscience
TWST
$4.37B
| $67.8M | 0.44% |
1,427,650
+1,420,000
|
|
||
39
Baidu
BIDU
$45.1B
| $49.4M | 0.32% |
443,785
+128,485
|
|
||
40
CG Oncology
CGON
$4.8B
| $45.6M | 0.3% |
674,000
+666,000
|
|
||
41
AstraZeneca
AZN
$273B
| $44.7M | 0.29% |
+226,499
|
|
||
42
Merck
MRK
$286B
| $43.4M | 0.28% |
+361,000
|
|
||
43
Acadia Healthcare
ACHC
$2.37B
| $40.6M | 0.26% |
+1,736,800
|
|
||
44
Welltower
WELL
$138B
| $39.5M | 0.26% |
200,000
-143,000
|
|
||
45
Immunovant
IMVT
$6.4B
| $38.4M | 0.25% |
1,546,000
+1,534,000
|
|
||
46
Enanta Pharmaceuticals
ENTA
$350M
| $36.3M | 0.24% |
2,871,862
+99,600
|
|
||
47
Johnson & Johnson
JNJ
$537B
| $36.2M | 0.24% |
+148,000
|
|
||
|
BBNX
48
Beta Bionics
BBNX
$570M
| $36.2M | 0.24% |
3,607,920
-706,000
|
|
||
49
Assembly Biosciences
ASMB
$485M
| $34.1M | 0.22% |
1,227,590
|
|
||
|
JOYY
50
JOYY Inc
JOYY
$3.46B
| $33.8M | 0.22% |
578,200
|
|